SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN)

277 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q4 2022.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 257 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 55.8M shares of 56M outstanding shares and own 99.72% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.6M shares), VANGUARD GROUP INC (5.79M shares), ARMISTICE CAPITAL, LLC (4.36M shares), MACQUARIE GROUP LTD (2.42M shares), DIMENSIONAL FUND ADVISORS LP (2.38M shares), STATE STREET CORP (1.89M shares), Stephens Investment Management Group LLC (1.6M shares), LOOMIS SAYLES & CO L P (1.56M shares), GW&K Investment Management, LLC (1.41M shares), and RENAISSANCE TECHNOLOGIES LLC (1.26M shares).
This table shows the top 257 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.